Suppr超能文献

[分枝杆菌生长指示管(MGIT)用于结核分枝杆菌分离株药敏试验的评估]

[Evaluation of mycobacteria growth indicator tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis isolates].

作者信息

Suzuki K, Tsuyuguchi K, Matsumoto H, Niimi A, Tanaka E, Murayama T, Amitani R, Kuze F

机构信息

Department of Infection and Inflammation, Kyoto University, Japan.

出版信息

Kekkaku. 1997 Apr;72(4):187-92.

PMID:9145648
Abstract

Fifty six clinical isolates of Mycobacterium tuberculosis were tested for drug susceptibility in Mycobacteria Growth Indicator Tube (MGIT) containing 0.1 microgram/ml of INH, 1.0 microgram/ml of RFP, 3.5 micrograms/ml of EB and 0.8 microgram/ml of SM. These results were compared with those obtained by testing the same M.tuberculosis isolates by the absolute concentration method using 1% Ogawa egg slant containing 0.1 microgram/ml of INH, 10 micrograms/ml of REP, 2.5 micrograms/ml of EB and 20 micrograms/ml of SM. Fifty six isolates consisted of 18 pansensitive strains, 27 multidrug resistant strains and 11 single drug resistant strains. The results of individual drugs showed excellent agreement between the MGIT and the Ogawa methods, and overall agreement rate of the two methods were 96.4%. The results were just the same for all drugs in 48 out of 56 strains studied. The drug resistance could be observed much earlier by the MGIT method (mean 5.9 days) than by the Ogawa method (more than 21 days). In conclusion, the MGIT system could be a promising new drug susceptibility test which might become available in Japan replacing the Ogawa method.

摘要

对56株结核分枝杆菌临床分离株进行了药敏试验,在含有0.1微克/毫升异烟肼、1.0微克/毫升利福平、3.5微克/毫升乙胺丁醇和0.8微克/毫升链霉素的分枝杆菌生长指示管(MGIT)中进行。将这些结果与通过绝对浓度法对相同结核分枝杆菌分离株进行检测所获得的结果进行比较,绝对浓度法使用含有0.1微克/毫升异烟肼、10微克/毫升利福平、2.5微克/毫升乙胺丁醇和20微克/毫升链霉素的1%小川鸡蛋斜面。56株分离株包括18株全敏感菌株、27株多药耐药菌株和11株单药耐药菌株。各药物的结果显示MGIT法和小川法之间具有良好的一致性,两种方法的总体一致率为96.4%。在所研究的56株菌株中,48株所有药物的结果均相同。MGIT法(平均5.9天)比小川法(超过21天)能更早观察到耐药性。总之,MGIT系统可能是一种有前景的新药敏试验方法,有望在日本取代小川法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验